Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03717753 · ClinicalTrials.gov registry record · NA
Rotator Cuff Pathway
A NA study of Shoulder Pain, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT03717753: Completed NA study of Shoulder Pain, sponsored by Hospital for Special Surgery, New York.
NCT03717753 is a NA study of Shoulder Pain that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 140 participants, above the 96-participant average among 27 other Shoulder Pain trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03717753, a NA study of Shoulder Pain, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
Rotator cuff surgery is mostly performed on an outpatient basis, and many patients still experience moderate to severe pain after surgery, despite the use of regional anesthesia and opioids. The specific aim is to determine whether a comprehensive pathway that includes a well-defined regional technique and multimodal analgesia will reduce the worst pain with movement 0-48 hours after block placement compared to the current standard practice. This is a 'before and after' study. We plan to have 70 patients studied prior to initiation of a pathway, and 70 patients studied after initiation of a pathway. Both groups will receive identical postoperative follow-up.
Primary Outcome
worst NRS with movement. A lower score is a better outcome. The score range is between 0 and 10.
Conditions Studied
Interventions
- OTHER Pathway
Study Locations (1)
New York
- Hospital of Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
What the finished NCT03717753 record still lists
NCT03717753 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 27 other Shoulder Pain trials with a reported enrollment target (46% higher).
The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 1 intervention - of which Pathway is the first listed.
NCT03717753 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03717753 about?
NCT03717753 is a clinical study titled "Rotator Cuff Pathway". Rotator cuff surgery is mostly performed on an outpatient basis, and many patients still experience moderate to severe pain after surgery, despite the use of regional anesthesia and opioids. The specific aim is to determine whether a comprehensive pathway that includes a well-defined regional techni...
What is the current status of trial NCT03717753?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-09-07. Estimated completion is 2020-03-01.
What conditions does trial NCT03717753 study?
This clinical trial studies the following conditions: Shoulder Pain.
What interventions are being tested in trial NCT03717753?
The interventions under investigation include: Pathway (OTHER).
Who is sponsoring clinical trial NCT03717753?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03717753 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03717753's enrollment target sits among peer trials
140 6th of 27 higher than 22 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Outcomes Collection: How Can we do Better?
RECRUITING · NA
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
BFRT for Subacromial Pain
RECRUITING · NA
-
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain
ACTIVE NOT RECRUITING · NA
-
How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI